Location permission needed for a better experience.
How can we help you?
EN
Hızlı Randevu
Hastane
Randevusu
Görüntülü Görüşme Randevusu

Profesör veya doçent doktor tercihinizde öğretim üyesi farkı oluşabilir. Ayrıca kurumlara ait uygulama esasları farklılık gösterebilir.

Education
  • 2009 Gülhane Askeri Tıp Akademisi Askeri Faculty of Medicine Associate Professor
  • 2004 Gülhane Askeri Tıp Akademisi Tıbbi Onkoloji
  • 2000 Gülhane Askeri Tıp Akademisi İç Hastalıkları
  • 1993 Gülhane Askeri Tıp Akademisi Faculty of Medicine
Experience
  • 2025 Acıbadem Healthcare Services
  • 2005 - 2012 GATA Tıbbi Onkoloji Bilim Dalı
  • 1994 - 1996 TC Donanma Komutanlığı, Akü Batarya Fabrikası
Memberships
  • Tıbbi Onkoloji Association
  • Tıbbi Onkoloji Association Destek Tedaviler Çalışma Grubu
  • Türk Hematoloji Association
  • European Society of Medical Oncology
  • Antalya Meme Hastalıkları Association
PUBLICATIONS
  • Gemsitabinin multipl myelom (RPMI-8226) ve IgG plazma hücreli lösemi (ARH 77) hücre hatları üzerindeki sitotoksik etkisi Gülhane Tıp Dergisi, 54:263-266; 2012. Çoban,Z., Avcu, F., Ural A.U., Kuzhan, O., Güran, Ş
  • Phase II study of loading-dose ibandronate treatment in patients with breast cancer and bone metastases suffering from moderate to severe pain. Onkologie. 2012;35(5):254-8. doi: 10.1159/000338369. Epub 2012 Apr 24. PubMed PMID: 22868504. Altundag K, Dizdar O, Ozsaran Z, Ozkok S, Saip P, Eralp Y, Komurcu S, Kuzhan O, Ozguroglu M, Karahoca M.
  • Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-D-glucose with positron emission tomography in patients with small cell lung cancer. Ann Nucl Med. 2011 Jul;25(6):406-13. doi: 10.1007/s12149-011-0478-y. Epub 2011 Mar 17. PubMed PMID: 21409347. Arslan N, Tuncel M, Kuzhan O, Alagoz E, Budakoglu B, Ozet A, Ozguven MA.
  • Factors affecting engraftment time in autologous peripheral stem cell transplantation. Asian Pac J Cancer Prev. 2010;11(3):697-702.PubMedPMID: 21039038. Turk HM, Komurcu S, Arpaci F, Ozet A, Kilic S, Kuzhan O, Ozturk B, Yilmaz I, Ataergin S, Ozturk M.
  • Efficacy of melatonin, mercaptoethylguanidine and 1400W in doxorubicin- and trastuzumab-induced cardiotoxicity. Oter S, Korkmaz A./ J Pineal Res. 2011 Jan;50(1):89-96. doi: 10.1111/j.1600-079X.2010.00818.x. Epub 2010 Nov 9. PubMed PMID: 21062350. Ozturk M,Ozler M,Kurt YG,Ozturk B,Uysal B,Ersoz N,Yasar M,Demirbas S,Kurt B,Acikel C,Oztas Y,Arpaci F,Topal T,Ozet A,Ataergin S,Kuzhan O,Oter S,
.
.
.

Contact Us

Fill out the form below for your information requests

As Acıbadem Healthcare Group, you can report your requests, suggestions, thanks and complaints by filling out the form below or by contacting us at +90 538 685 39 52 so that we can provide you with a better and higher quality service.

See More
See More
Security Code

INFORMATION NOTICE ON THE PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. and its controlling and affiliated companies listed in Annex-1 (each referred to individually as the "Company" and collectively as the "Companies") process your general and/or special category personal data (including but not limited to health data) ("Personal Data") in the capacity of Data Controller under the Personal Data Protection Law No. 6698 ("Law") and related legislation. Processing of Personal Data is carried out in accordance with the framework outlined below and in compliance with the Fundamental Law on Health Services No. 3359, the Decree Law No. 663 on the Organization and Duties of the Ministry of Health and its Affiliated Institutions, the Regulation on the Provision of Remote Health Services, the Private Hospitals Regulation, the Ministry of Health regulations, and other relevant legislation.

I. Acquisition, Processing, and Purposes of Processing Personal Data

Your Personal Data is obtained through verbal, written, visual, or electronic channels (such as our website, mobile applications, and call center) for the purposes of protecting public health, preventive medicine, medical diagnosis, treatment and care services, and the planning and management of healthcare services and their financing, in alignment with the Company's fields of activity. The Personal Data processed by the Company, including but not limited to the following, is collected and processed proportionally and in connection with these purposes:

Your Personal Data may be processed under the conditions specified in Articles 5 and 6 of the Law for the following purposes:

II. Transfer of Personal Data

Your Personal Data may be shared with:

III. Method and Legal Basis for Collecting Personal Data

Your Personal Data is collected through verbal, written, visual, or electronic means for the lawful execution of the Company's activities and compliance with contractual and legal obligations. The legal basis for collection includes:

As per Article 6 - (3) of the Law, personal data related to health and sexual life may be processed without explicit consent by persons or institutions subject to confidentiality obligations for public health protection, preventive medicine, medical diagnosis, treatment, and care services, as well as the planning and management of healthcare financing.

IV. Your Rights Regarding the Protection of Personal Data

Under Article 11 of the Law, you have the right to:

V. Data Security

The Companies ensure the security of Personal Data by implementing necessary technical and administrative measures in accordance with information security standards and procedures.

VI. Complaints and Contact Information

To exercise your rights under the Law, you may submit a request through the methods specified in the "Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. Data Subject Application Form" available at https://www.acibadem.com.tr/acibademonline/images/Ac%C4%B1badem_Veri_Sahibi_Basvuru_Formu.pdf.

Requests can be submitted by mail, notarized document, or secure electronic means to:

ANNEX-1: List of Companies

 

TOP x""